Gut restricted-7 is primarily used in the development of pharmaceuticals aimed at treating gastrointestinal disorders. It is designed to act locally within the gut, minimizing systemic absorption and reducing potential side effects. This compound is particularly effective in managing conditions such as irritable bowel syndrome (IBS) and inflammatory bowel disease (IBD), where it helps to reduce inflammation and restore normal gut function. Additionally, it is being explored for its potential in targeted drug delivery systems, ensuring that therapeutic agents are released directly in the intestinal tract for optimal efficacy. Its gut-restricted nature makes it a promising candidate for safer and more effective treatments for a range of digestive health issues.